72 related articles for article (PubMed ID: 20221865)
1. ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
Datta G; Chaddha M; Handattu SP; Palgunachari MN; Nayyar G; Garber DW; Gupta H; White CR; Anantharamaiah GM
Adv Exp Med Biol; 2010; 660():1-4. PubMed ID: 20221865
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein Mimetic Peptides as Modulators of Lipoprotein Function.
Anantharamaiah GM; Garber DW; White CR
Protein Pept Lett; 2016; 23(11):1024-1031. PubMed ID: 27586181
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E mimetic Peptide dramatically lowers plasma cholesterol and restores endothelial function in watanabe heritable hyperlipidemic rabbits.
Gupta H; White CR; Handattu S; Garber DW; Datta G; Chaddha M; Dai L; Gianturco SH; Bradley WA; Anantharamaiah GM
Circulation; 2005 Jun; 111(23):3112-8. PubMed ID: 15939819
[TBL] [Abstract][Full Text] [Related]
4. The effect of HDL mimetic peptide 4F on PON1.
Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
[TBL] [Abstract][Full Text] [Related]
6. Two adjacent domains (141-150 and 151-160) of apoE covalently linked to a class A amphipathic helical peptide exhibit opposite atherogenic effects.
Nayyar G; Handattu SP; Monroe CE; Chaddha M; Datta G; Mishra VK; Keenum TD; Palgunachari MN; Garber DW; Anantharamaiah GM
Atherosclerosis; 2010 Dec; 213(2):449-57. PubMed ID: 21030022
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory properties of paraoxonase-1 in atherosclerosis.
Mackness B; Mackness M
Adv Exp Med Biol; 2010; 660():143-51. PubMed ID: 20221877
[TBL] [Abstract][Full Text] [Related]
8. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Wagner AC; Hama S; Hough G; Bachini E; Garber DW; Mishra VK; Palgunachari MN; Fogelman AM
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1932-7. PubMed ID: 15961700
[TBL] [Abstract][Full Text] [Related]
9. Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques.
Anantharamaiah GM; Garber DW; Goldberg D; Morrel E; Datta G; Palgunachari MN; Register TC; Appt SE; White CR
J Lipid Res; 2018 Nov; 59(11):2075-2083. PubMed ID: 30201630
[TBL] [Abstract][Full Text] [Related]
10. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Frank JS; Grijalva VR; Ganesh VK; Mishra VK; Palgunachari MN; Fogelman AM
Circ Res; 2005 Sep; 97(6):524-32. PubMed ID: 16100046
[TBL] [Abstract][Full Text] [Related]
11. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E mimetics and cholesterol-lowering properties.
Sharifov OF; Nayyar G; Garber DW; Handattu SP; Mishra VK; Goldberg D; Anantharamaiah GM; Gupta H
Am J Cardiovasc Drugs; 2011 Dec; 11(6):371-81. PubMed ID: 22149316
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical utility of high-density lipoprotein-mimetic peptides.
Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
[TBL] [Abstract][Full Text] [Related]
15. A new recombinant human apolipoprotein E mimetic peptide with high-density lipoprotein binding and function enhancing activity.
Zhao W; Du F; Zhang M; Sun S; Yu H; Fan D
Exp Biol Med (Maywood); 2011 Dec; 236(12):1468-76. PubMed ID: 22087021
[TBL] [Abstract][Full Text] [Related]
16. The contribution of high density lipoprotein apolipoproteins and derivatives to serum paraoxonase-1 activity and function.
James RW; Deakin SP
Adv Exp Med Biol; 2010; 660():173-81. PubMed ID: 20221880
[TBL] [Abstract][Full Text] [Related]
17. Systemic inflammation, intestine, and paraoxonase-1.
Vakili L; Navab KD; Shabihkhani M; Pourtabatabaei N; Vazirian S; Barseghian Z; Seyedali S; Hough G
Adv Exp Med Biol; 2014; 824():83-8. PubMed ID: 25038995
[TBL] [Abstract][Full Text] [Related]
18. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
[TBL] [Abstract][Full Text] [Related]
19. ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.
Gaidukov L; Viji RI; Yacobson S; Rosenblat M; Aviram M; Tawfik DS
Biochemistry; 2010 Jan; 49(3):532-8. PubMed ID: 20025294
[TBL] [Abstract][Full Text] [Related]
20. Retention of α-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency.
Zheng Y; Patel AB; Narayanaswami V; Bielicki JK
Biochem Biophys Res Commun; 2013 Nov; 441(1):71-6. PubMed ID: 24129191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
